Published in Ned Tijdschr Geneeskd on May 17, 2003
[Kidney transplantation: more kidneys from living donors, individualised immunosuppression and better results]. Ned Tijdschr Geneeskd (2003) 1.38
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med (1998) 3.86
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation (1999) 2.27
Variability of relative blood volume during haemodialysis. Nephrol Dial Transplant (2000) 2.10
Sequential measurements of soluble interleukin 2 receptor levels in plasma of heart transplant recipients. Transplantation (1990) 2.06
[Two pregnant women with shortness of breath due to peripartum cardiomyopathy]. Ned Tijdschr Geneeskd (2006) 2.02
A criminological perspective: why prohibition of organ trade is not effective and how the Declaration of Istanbul can move forward. Am J Transplant (2011) 1.92
Randomized phase 2b trial of tofacitinib (CP-690,550) in de novo kidney transplant patients: efficacy, renal function and safety at 1 year. Am J Transplant (2012) 1.79
Interferon-alpha 2b for refractory ocular Behçet's disease. Lancet (1994) 1.65
Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. Transplantation (2000) 1.55
Contrasting response to cyclosporin in refractory nephrotic syndrome. Clin Nephrol (1989) 1.48
[The application of electric heart assist devices in 3 patients with end-stage heart failure as a bridge to transplantation]. Ned Tijdschr Geneeskd (2002) 1.47
Ultrafiltration improves aortic compliance in haemodialysis patients. J Hum Hypertens (2005) 1.46
Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction. Transplantation (2000) 1.43
Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev (2007) 1.43
The TNF-alpha system in heart failure and after heart transplantation: plasma protein levels, mRNA expression, soluble receptors and plasma buffer capacity. Eur Heart J (1999) 1.42
The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation. Clin Pharmacol Ther (1998) 1.42
Hepatitis B and hemodialysis: the impact of universal precautions in preventing the transmission of bloodborne viruses. Infect Control Hosp Epidemiol (1998) 1.41
Successful treatment of Kaposi's sarcoma in a renal allograft recipient. Nephrol Dial Transplant (1995) 1.41
Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells. Clin Exp Immunol (2010) 1.41
Increase in blood volume during dialysis without ultrafiltration. Blood Purif (2001) 1.40
Functional responses of T cells blocked by anti-CD25 antibody therapy during cardiac rejection. Transplantation (2000) 1.40
[Favourable results of the first 2 years of the Dutch paired, living donor, kidney exchange programme]. Ned Tijdschr Geneeskd (2007) 1.39
[Behcet's disease]. Ned Tijdschr Geneeskd (1999) 1.39
Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression. Transplantation (2001) 1.39
[Kidney transplantation: more kidneys from living donors, individualised immunosuppression and better results]. Ned Tijdschr Geneeskd (2003) 1.38
Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients. Lancet (1984) 1.37
Adalimumab: a new modality for Behçet's disease? Ann Rheum Dis (2006) 1.20
Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion. Ther Drug Monit (2001) 1.17
Auxiliary partial liver transplantation for end-stage chronic liver disease. N Engl J Med (1988) 1.14
Detection of multiple 'Ebnotypes' in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx. J Gen Virol (1994) 1.12
Anti-TNF-alpha therapy for sight threatening uveitis. Br J Ophthalmol (2005) 1.12
Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation (2001) 1.10
The effect of etanercept on Graves' ophthalmopathy: a pilot study. Eye (Lond) (2005) 1.09
Doubt about the feasibility of preemptive genotyping. Clin Pharmacol Ther (2012) 1.08
Phase 1 dose-escalation study of CP-690 550 in stable renal allograft recipients: preliminary findings of safety, tolerability, effects on lymphocyte subsets and pharmacokinetics. Am J Transplant (2008) 1.05
In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci (1991) 1.04
Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs. Br J Cancer (2013) 1.03
Double-blind study of leucocyte interferon administration in chronic HBsAg-positive hepatitis. Lancet (1980) 1.02
Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes. Br J Ophthalmol (2004) 1.02
Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator. Lancet (1981) 1.01
The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysis. Transplantation (2003) 1.01
Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med (1989) 1.01
Genetic variation in the CYP2D6 gene is associated with a lower heart rate and blood pressure in beta-blocker users. Clin Pharmacol Ther (2008) 1.00
Somatostatin and somatostatin receptors in the immune system: a review. Eur Cytokine Netw (2000) 1.00
Antiviral effect of interferon in vivo may be mediated by the host. Nature (1979) 1.00
Changes in immunological parameters after conversion from cyclosporine A to azathioprine in renal transplant recipients. Int J Immunopharmacol (1989) 0.99
Ischemia times and donor serum creatinine in relation to renal graft failure. Transplantation (2003) 0.99
Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome. Clin Sci (Lond) (1992) 0.98
Production and initial characterization of rat interferon. J Gen Virol (1980) 0.98
Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation (1986) 0.98
UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients. Clin Pharmacol Ther (2009) 0.98
Follicular T helper cells and humoral reactivity in kidney transplant patients. Clin Exp Immunol (2015) 0.96
Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study. Nephrol Dial Transplant (1999) 0.96
Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†). Am J Transplant (2013) 0.96
Donor-derived mesenchymal stem cells remain present and functional in the transplanted human heart. Am J Transplant (2008) 0.95
Technical considerations and pitfalls in laparoscopic live donornephrectomy. Surg Endosc (2002) 0.95
Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients. Transplantation (1999) 0.95
Persistent Epstein-Barr virus infection and a histiocytic sarcoma in a renal transplant recipient. Cancer (1985) 0.94
Long-term graft survival after urological complications of 695 kidney transplantations. J Urol (2001) 0.94
The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer. Br J Cancer (2010) 0.94
Hypotension during hemodialysis results from an impairment of arteriolar tone and left ventricular function. Clin Nephrol (2005) 0.93
Is imatinib mesylate a promising drug in systemic sclerosis? Arthritis Rheum (2008) 0.93
The effect of low and ultra-low dosages Thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients. Transpl Immunol (2012) 0.93
The spectrum of structural abnormalities on CT scans from patients with CF with severe advanced lung disease. Thorax (2009) 0.92
Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients. Mol Psychiatry (2007) 0.92
Coronary artery disease after heart transplantation: timing of coronary arteriography. J Heart Lung Transplant (1993) 0.92
Influenza vaccination in dialysis and transplant patients. Antiviral Res (1985) 0.92
The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patients. Pharmacogenomics J (2009) 0.92
Immunosuppression should be stopped in patients with renal allograft failure. Clin Transplant (2001) 0.91
Long-term follow-up of a randomized trial comparing laparoscopic and mini-incision open live donor nephrectomy. Am J Transplant (2010) 0.91
The Jak inhibitor CP-690,550 preserves the function of CD4CD25FoxP3 regulatory T cells and inhibits effector T cells. Am J Transplant (2010) 0.91
The calcineurin inhibitor tacrolimus allows the induction of functional CD4CD25 regulatory T cells by rabbit anti-thymocyte globulins. Clin Exp Immunol (2010) 0.90
Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro. J Immunol Methods (2001) 0.90
Trivalent influenza vaccine in patients on haemodialysis: impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine components. Vaccine (1987) 0.90
Cardiac sarcoidosis: Case-studies and a brief review of the literature. Neth Heart J (2002) 0.89
Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam Heart Transplant Program experience. Infection (1993) 0.89
Infections after renal allograft failure in patients with or without low-dose maintenance immunosuppression. Transplantation (1997) 0.89
Live donor nephrectomy and return to work: does the operative technique matter? Surg Endosc (2003) 0.89
A controlled study on the effect of mannitol on immediate renal function after cadaver donor kidney transplantation. Transplantation (1983) 0.89
Successful expansion of the living donor pool by alternative living donation programs. Am J Transplant (2009) 0.89
CD4+CD25bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients. Am J Transplant (2006) 0.89
The Dutch algorithm for allocation in living donor kidney exchange. Transplant Proc (2005) 0.88
Human adipose-tissue derived mesenchymal stem cells induce functional de-novo regulatory T cells with methylated FOXP3 gene DNA. Clin Exp Immunol (2013) 0.88
Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics. J Pharmacol Exp Ther (1999) 0.88
The detection of cytotoxic T cells with high-affinity receptors for donor antigens in the transplanted heart as a prognostic factor for graft rejection. Transplantation (1993) 0.87
Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies. Hum Gene Ther (2011) 0.87
Home-based family intervention increases knowledge, communication and living donation rates: a randomized controlled trial. Am J Transplant (2014) 0.87